Bristol Myers Squibb has agreed to pay up to $11.1 billion to partner with Germany's BioNTech and develop the latter's next-generation cancer immunotherapy, which could take on rival Merck & Co's ...

Bristol-Myers Squibb Co. will pay BioNTech SE as much as $11.1 billion to license a next-generation cancer drug, as competition intensifies in an area of oncology that seeks to harness the immune ...

NBA Props For Friday, April 11 NBA Player Prop Bet #1: Cade Cunningham Cade Cunningham 2024-2025 Season Stats PPG: 26 | FG: 53.5 % | FT: 66.7 % | 3PT : 35.4 % | REB: 5.3 | AST: 5.8 | STL: 1.0 | BLK: 0 ...